Neoplasms, Fibrous Tissue: Clinical Trials

447 trials for Neoplasms, Fibrous Tissue, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

241 completed, 59 recruiting, 40 terminated, 36 unknown. 181 Phase 2, 95 Phase 1, 66 Not applicable, 54 Phase 3, 13 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 2181Completed 101, Recruiting 23, Terminated 19, Active not recruiting 15, Unknown 12, Not yet recruiting 5, Withdrawn 5, Enrolling by invitation 1
Phase 195Completed 54, Recruiting 16, Active not recruiting 9, Terminated 9, Not yet recruiting 2, Unknown 2, Withdrawn 2, Enrolling by invitation 1
Not applicable66Completed 26, Recruiting 12, Not yet recruiting 11, Unknown 7, Terminated 4, Withdrawn 4, Active not recruiting 2
Phase 354Completed 36, Terminated 5, Unknown 4, Active not recruiting 3, Withdrawn 3, Recruiting 2, Not yet recruiting 1
Phase 413Completed 5, Unknown 3, Active not recruiting 2, Recruiting 2, Terminated 1
Early Phase 13Completed 2, Terminated 1

Follow Neoplasms, Fibrous Tissue: new trials by email Literature Review of Neoplasms, Fibrous Tissue trials Research Report on Neoplasms, Fibrous Tissue

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Doxorubicin With or Without DT-7012 in Advanced Soft Tissue Sarcoma
DT-7012, Doxorubicin - Undifferentiated Pleomorphic Sarcoma (UPS), Dedifferentiated Liposarcoma (DDLPS)
Phase 2Not yet recruitingGustave Roussy, Cancer Campus, Grand Paris802027-02-012026-09-15
A Safety Study of ST316 in Participants With Familial Adenomatous Polyposis (FAP).
ST316 IV - Familial Adenomatous Polyposis (FAP)
Phase 1Not yet recruitingSapience Therapeutics402027-01-042026-08-12
Combination of Avutometinib and Defactinib for Treatment of Relapsed, Refractory, Metastatic, or Unresectable Malignant Peripheral Nerve Sheath Tumor
avutometinib capsule + defactinib tablet - MPNST (Malignant Peripheral Nerve Sheath Tumor)
Phase 2Not yet recruitingGirish Dhall, MD252027-01-012026-10-28
DEPART Study at Yale
Radiation Therapy - Dupuytren's Contracture
Phase 3Not yet recruitingYale University1582026-11-012026-10-13
Management of Breast Fibroadenoma: Comparing Observation, Microwave Ablation, and Surgical Excision
Ultrasound-guided percutaneous microwave ablation, Conventional open surgical excision - Fibroadenoma, Breast Fibroadenoma
Not applicableNot yet recruitingSohag University602026-11-012026-10-22
Understanding Patient Preferences When Deciding on a Voluntary Musculoskeletal Test
Diagnostic Advance Care Planning Discussion, Informational Statement Only - Non-traumatic Musculoskeletal Conditions, Carpal Tunnel Syndrome (CTS)
Not applicableNot yet recruitingUniversity of Texas at Austin2202026-10-252026-09-22
NAC-REPAIR for Post-surgical Pain
NAC, NAC 0mg/day (Placebo) - Carpal Tunnel Surgery, Trigger Finger Disorder
Phase 2Not yet recruitingUniversity of Arizona802026-10-152026-07-17
A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Soft Tissue Sarcoma
Lifileucel - Sarcoma, Soft Tissue Sarcoma (STS)
Phase 2RecruitingIovance Biotherapeutics, Inc.802026-10-022026-10-09
Patient-reported Outcomes Following Percutaneous Ablation of Desmoid Tumors
Desmoid tumor ablation - Desmoid Tumor, Aggressive Fibromatoses
Enrolling by invitationMayo Clinic302026-10-012026-09-29
Ultrasound-Guided Microwave Ablation for Breast Fibroadenoma: Safety and Cosmetic Outcomes
Ultrasound-Guided Microwave Ablation - Breast Fibroadenoma
Not applicableNot yet recruitingAl-Azhar University402026-10-012026-09-29
Kinesitherapy Plus Osteopathy After Surgery for Dupuytren Disease
Physiotherapy, Sham Osteopathy - Dupuytren Disease
Not applicableNot yet recruitingClinique Bizet502026-09-302026-10-30
SBRT Combined With Reduced-Dose Anthracycline Chemotherapy and Toripalimab as Neoadjuvant Therapy for Localized High-Risk Undifferentiated Pleomorphic Sarcoma
Toripalimab, Liposomal doxorubicin, Stereotactic body radiotherapy (SBRT) - Undifferentiated Pleomorphic Sarcoma (UPS)
Phase 2Not yet recruitingTianjin Medical University Cancer Institute and Hospital392026-09-012026-09-14
Trial of Selumetinib and Bromodomain Inhibitor With Durvalumab for Sarcomas
Selumetinib + ZEN-3694 ± Durvalumab - MPNST, NF1
Phase 2RecruitingUniversity of Alabama at Birmingham412026-08-042026-08-24
Safety and Efficacy of BMS-986504 in Unresectable Malignant Peripheral Nerve Sheath Tumor
BMS-986504 - Malignant Peripheral Nerve Sheath Tumors, MPNST
Phase 1 / Phase 2RecruitingAnkit Mangla, MD172026-08-012026-08-11
Value of Ultrasound-Guided Microwave Ablation for Breast Fibroadenoma
microwave ablation - Breast Fibroadenoma
Not applicableNot yet recruitingAssiut University452026-08-012026-07-22
Exploratory Study on Toripalimab and Anlotinib Combined With Standard Chemotherapy for Refractory Dermatofibrosarcoma Protuberans
Toripalimab, Anlotinib, Standard Chemotherapy - Dermatofibrosarcoma Protuberans (DFSP)
Phase 2Not yet recruitingYanjie Zhang, MD202026-06-152026-06-16
Early Phase Study Evaluating MEK and MDM2 Inhibition in Patients With NF1 and MPNST
APG-115, Selumetinib - Malignant Peripheral Nerve Sheath Tumor (MPNST), Neurofibromatosis 1 (NF1)
Phase 1 / Phase 2RecruitingAeRang Kim452026-06-012026-07-27
The Impact of Myomectomy on IVF Outcomes: A Multicenter Randomized Controlled Trial
Myomectomy - Infertility, In Vitro Fertilization (IVF)
Not applicableNot yet recruitingPeking Union Medical College Hospital7922026-05-012026-05-11
A Study in Adults With Desmoid Tumors
ES014 - Desmoid Tumor
Phase 2RecruitingElpiscience (Suzhou) Biopharma, Ltd.502026-04-242026-10-21
DoD Award NF230020 Identification of Metabolic Markers and Statistical Prediction of MPNST for Rapid Diagnosis and Assessment of Surgical Margins
Neurofibromas, MPNST
RecruitingM.D. Anderson Cancer Center602026-04-022026-09-18

Showing 20 of 447. Sign in to see all of them.

Narrower conditions

Sarcoma (126)  ·  Neurofibrosarcoma (97)  ·  Histiocytoma, Malignant Fibrous (91)  ·  Dupuytren Contracture (76)  ·  Leiomyosarcoma (73)  ·  Liposarcoma (73)  ·  Fibrosarcoma (68)  ·  Desmoid Tumors (67)  ·  Sarcoma, Synovial (59)  ·  Ovarian Neoplasms (56)  ·  Hemangiosarcoma (55)  ·  Brenner Tumor (51)  ·  Fallopian Tube Neoplasms (42)  ·  Dermatofibrosarcoma (41)  ·  Rhabdomyosarcoma (40)

Broader conditions

Neoplasms by Histologic Type (446)  ·  Neoplasms, Connective Tissue (446)  ·  Neoplasms, Connective and Soft Tissue (445)  ·  Neoplasms (423)  ·  Neoplasms, Glandular and Epithelial (167)  ·  Neoplasms by Site (159)  ·  Fibroma (143)  ·  Neoplasms, Nerve Tissue (129)  ·  Skin and Connective Tissue Diseases (128)  ·  Nervous System Diseases (117)  ·  Nervous System Neoplasms (107)  ·  Neuromuscular Diseases (104)  ·  Peripheral Nervous System Diseases (103)  ·  Urogenital Diseases (101)

Interventions

Doxorubicin (28)  ·  Paclitaxel (26)  ·  Carboplatin (25)  ·  Radiotherapy (23)  ·  Ifosfamide (19)  ·  Taxes (17)  ·  Bevacizumab (16)  ·  Cisplatin (16)  ·  Microbial Collagenase (16)  ·  Imatinib Mesylate (13)  ·  xiapex (12)  ·  pembrolizumab (11)  ·  Magnetic Resonance Spectroscopy (10)  ·  Nivolumab (10)  ·  Chemotherapy, Adjuvant (9)

Sponsors

National Cancer Institute (NCI) (51)  ·  Gynecologic Oncology Group (20)  ·  European Organisation for Research and Treatment of Cancer - EORTC (17)  ·  Endo USA Inc., a Keenova Therapeutics Company (13)  ·  Children's Oncology Group (12)  ·  Mayo Clinic (10)  ·  Memorial Sloan Kettering Cancer Center (10)  ·  M.D. Anderson Cancer Center (8)  ·  Theraclion (7)  ·  Universitaire Ziekenhuizen KU Leuven (7)  ·  Alliance for Clinical Trials in Oncology (6)  ·  Fondazione IRCCS Istituto Nazionale dei Tumori, Milano (6)  ·  Sarcoma Alliance for Research through Collaboration (6)  ·  Istituto Ortopedico Rizzoli (5)  ·  Oslo University Hospital (5)

Countries

United States (263)  ·  Canada (42)  ·  France (42)  ·  United Kingdom (38)  ·  Germany (28)  ·  Belgium (27)  ·  Italy (27)  ·  Netherlands (24)  ·  Australia (22)  ·  Spain (22)  ·  Denmark (19)  ·  China (13)  ·  Japan (13)  ·  Norway (12)  ·  Switzerland (12)

Top investigators

Ilse Degreef, Prof. Dr. (5)  ·  AeRang Kim, MD, PhD (4)  ·  Hedy Kindler (4)  ·  Peter G. Rose, MD (4)  ·  Silvia Stacchiotti, MD (4)  ·  Brigitte C Widemann, M.D. (3)  ·  Dennis Wigle, MD, PhD (3)  ·  Don Dizon (3)  ·  Veronica Urdaneta, MD (3)  ·  Veronica Urdaneta, MD, MPPH (3)  ·  William Tap, MD (3)  ·  Arkadiusz Dudek, MD (2)  ·  Brigitte C. Widemann, MD (2)  ·  Brigitte Widemann, MD (2)

Results publications

PMID 31401903, PMID 37185961, PMID 19451433, PMID 21941283, PMID 30633128, PMID 32827353, PMID 11705489, PMID 12528778, PMID 12957454, PMID 15010069, PMID 15084390, PMID 15177491, PMID 15592836, PMID 15659504, PMID 16110020, PMID 16368440, PMID 16394300, PMID 16412499, PMID 16515585, PMID 16528479, PMID 16631245, PMID 16959305, PMID 17095209, PMID 17109446, PMID 17264340, PMID 17290057, PMID 17336054, PMID 17634494, PMID 17906207, PMID 18006112, PMID 18430468, PMID 18640939, PMID 19088049, PMID 19451429, PMID 19596139, PMID 19671873, PMID 19726771, PMID 19768644, PMID 20338746, PMID 20434400, PMID 20471824, PMID 20525721, PMID 20622000, PMID 20837357, PMID 20932656, PMID 21529904, PMID 21684151, PMID 21967070, PMID 22119995, PMID 22197613

NIH funding

U10CA027469 (17), U10CA180868 (10), U10CA031946 (9), U10CA032102 (7), U10CA180821 (6), U10CA098543 (5), P30CA014599 (4), U10CA101165 (4), 2015 (3), N01CM00071 (3), P30CA008748 (3), U10CA180830 (3), U10CA180886 (3), 2009 (2), N01CM17102 (2)